All Cause Mortality clinical trials

Explore recruiting all cause mortality clinical trials.

Recruiting all cause mortality studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

All Cause Mortality trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of early dexamethasone on major complications and all-cause mortality in severe burns

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A prospective, multinational, multicenter, randomized, sequential, double-blind, placebo-controlled, phase 2a clinical study to assess the safety and pharmacokinetics (PK) of OMN6 in hospital-acquired bacterial pneumonia (HABP) or ventilated-associated bacterial pneumonia (VABP) caused by Acinetobacter baumannii complex (ABC).

Italy, Hungary, Greece

Therapeutic exploratory (Phase II) EU CTIS Study details

TRITON-CM: A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nucresiran in Patients with Transthyretin-Mediated Amyloidosis with Cardiomyopathy (ATTR amyloidosis with cardiomyopathy)

France, Germany, Italy, Greece, Belgium, Portugal +12 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, placebo-controlled, double-blind, multi-center, phase III trial to assess the efficacy and safety of trimodulin (BT588) in adult hospitalized subjects with severe community-acquired pneumonia (sCAP)

Romania, Ireland, Germany, Spain, Belgium, Austria +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Rifampin-free regimen versus rifampin-containing regimen in the treatment of staphylococcal prosthetic valve endocarditis: a multicenter randomized controlled non-inferiority study (RIFREE)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prehospital pulse-dose glucocorticoid in patients with STEMI – the PULSE-MI 2 trial

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

All Cause Mortality trials by city

All Cause Mortality in Toronto All Cause Mortality in Vancouver All Cause Mortality in Montreal All Cause Mortality in Calgary All Cause Mortality in Edmonton All Cause Mortality in Ottawa All Cause Mortality in Winnipeg All Cause Mortality in Quebec City All Cause Mortality in Hamilton All Cause Mortality in Kitchener All Cause Mortality in London All Cause Mortality in Halifax All Cause Mortality in New York All Cause Mortality in Los Angeles All Cause Mortality in Chicago All Cause Mortality in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease